
Standard antidepressants can take several weeks to provide meaningful relief. Ketamine for suicidal thoughts has attracted attention because it can reduce severe symptoms much faster. It doesn’t replace emergency support or ongoing care, but it can fill an important gap for some people.
- Ketamine can reduce severe depressive and suicidal symptoms within hours, while standard antidepressants often take weeks.
- Evidence is strongest for intravenous ketamine given in repeated doses; intranasal esketamine shows clearer effects on depression than on suicidal ideation itself.
- Spravato is FDA approved and requires at least two hours of monitoring at a certified health care setting under a federal safety program.
- Ketamine is not appropriate for everyone, and both ketamine and esketamine are controlled substances that can be misused.
- Ketamine is never a replacement for crisis care or an ongoing safety and treatment plan.
Understanding Suicidal Ideation
Suicidal ideation means having thoughts about suicide. These can range from vague feelings of not wanting to live to a crisis in which someone has a plan in place. Any mention of suicidal thoughts should be met with direct support.
Unfortunately, suicidal ideation is more common than you might expect. The Centers for Disease Control and Prevention reports that an estimated 14.3 million adults seriously considered suicide and 4.6 million made a plan in 2024. These thoughts can often happen when someone is struggling with conditions like major depression or substance use disorders. Life events such as grief or trauma can also raise the risk.
How Ketamine for Suicidal Thoughts Fills a Treatment Gap
Standard antidepressants are still important, but they don’t provide immediate relief of symptoms. Someone with strong suicidal thoughts needs help right away.
During this time, clinicians may use crisis intervention, safety planning, therapy, medication management or even hospitalization to keep someone safe. Ketamine is of interest because it can help some people feel better within hours of receiving treatment.
How Ketamine Works
Ketamine is an anesthetic that affects glutamate, a key brain chemical. Both ketamine and esketamine work on the NMDA receptor in the brain. Experts still do not know exactly how ketamine works as an antidepressant. The FDA says esketamine blocks the NMDA receptor.
Not everyone responds to ketamine. Even if mood improves quickly, it doesn’t mean the risk of suicide is gone.
What the Research Shows
A 2025 systematic review of clinical trials published since 2020 found that ketamine and S-ketamine can reduce suicidal thoughts for some patients. The strongest results came from intravenous treatment and repeated doses.
Research into intranasal treatment of S-ketamine, also called esketamine, found clearer improvements in depression symptoms than in suicidal ideation itself.
Esketamine is sold under the brand name Spravato. The FDA has approved it for two separate uses: treatment-resistant depression in adults, and depressive symptoms in adults with major depressive disorder who have acute suicidal ideation or behavior.
The results remain promising but are still very limited. For now, the evidence supports ketamine as a rapid treatment option that must form part of a wider safety and mental health care plan.
What Ketamine Treatment Looks Like
Ketamine treatment should happen in a medical setting with trained staff. Before starting, the team does a full psychiatric and medical check. They look at your medications, physical health, substance use history and past treatments.
With intravenous (IV) ketamine, a clinician gives a set dose through an IV. Staff monitor your blood pressure, heart rate, oxygen levels and mental state. You stay under observation until the effects wear off.
Spravato follows a separate FDA safety program called a Risk Evaluation and Mitigation Strategy (REMS). Patients use the nasal spray at a certified health care setting. The FDA requires monitoring for at least 2 hours due to the risk of serious side effects, such as breathing problems. Patients need transportation home and should not drive for at least a day.
Who Is and Is Not a Candidate
Our clinicians generally consider ketamine for adults with severe depression, especially when several treatments have not worked. Your care team also considers the severity of the symptoms and previous treatment response.
May Be Considered
- Adults with severe depression
- People whose symptoms persist after several treatments have not worked
- Patients whose symptom severity supports rapid intervention
- Some patients with a history of substance use, evaluated case by case
May Not Be Appropriate
- Children and adolescents, as Spravato is not approved for this age group
- Uncontrolled high blood pressure
- Certain blood vessel problems or a history of brain bleeding
- Pregnancy
- Active psychosis or mania
Having a history of substance use does not always mean you cannot get treatment. Still, ketamine and esketamine are controlled substances and can be misused or lead to dependence.
Safety and Side Effects
Common short-term side effects include:
- Dizziness and nausea
- Sleepiness
- Changes in perception and feeling disconnected
- A brief rise in blood pressure
- Anxiety, vomiting or trouble focusing
More serious risks include breathing problems, marked blood pressure changes and misuse. Buying ketamine online or using it without a doctor’s supervision is unsafe.





